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Summary: 
            
This crisis presents a unique opportunity to align COVID-19 services with those already in 
place for HIV, TB, Malaria, and other non-communicable diseases (NCDs) through 
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Abstract 
The arrival of COVID-19 to the African continent resulted in a range of locally relevant 
lockdown measures, which curtailed the spread of SARS-CoV-2 but caused economic 
hardship for large sections of the population. African countries now face difficult choices 
regarding easing of lockdowns and sustaining effective public health control measures and 
surveillance.  Control of the COVID-19 pandemic will require efficient community screening, 
testing, contact tracing, and behavioral change interventions, adequate resources, and a 
well-supported, community-based team of trained, protected personnel.  We discuss COVID-
19 screening-testing-contact tracing approaches used in selected African countries and the 
need for shared, affordable, innovative methods to overcome challenges and minimize 
mortality rates. This crisis presents a unique opportunity to align COVID-19 services with 
those already in place for HIV, TB, Malaria, and other non-communicable diseases (NCDs) 
through mobilization of Africa's inter-professional healthcare workforce to contain the 
pandemic. By addressing the challenges, the detrimental effect of the COVID-19 pandemic 
on African citizens can be minimized. 
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Introduction  
As of May 26th, 2020, the World Health Organization Africa Region (WHO-AFRO) has 
reported 80,979 COVID-19 cases with 2,193 deaths from 45 countries, with South Africa 
having the highest confirmed number of cases (23,615) [1]. Whilst these numbers are smaller 
than in the United States or Europe, the WHO estimates that up to 190,000 people could die 
in Africa from COVID-19 if not brought under control [2]. African countries face the difficult 
task of striking a delicate balance between institution of effective measures to curtail the 
spread of SARS-CoV-2 and minimization of economic hardship for large sections of the 
population by easing lockdown measures [3]. We discuss COVID-19 screening-testing-
contact tracing experiences from selected African countries and the need for shared, 
affordable approaches and innovations to overcome challenges and minimize mortality rates.  
 
Africa’s dilemma 
Scalable labor- and cost-efficient door-to-door contact tracing calls for increased manpower 
and national funding. Extensive human resource mobilization will be necessary to respond 
effectively [4]. Worryingly, only 15 African countries currently have health infrastructures that 
include a functioning national public health institute. COVID-19 surveillance post lockdown 
will require operations centers for proactive digitalized surveillance linked with capacity for 
rapid diagnostics and highly trained response teams. Nonetheless, these investment costs 
will need to be weighed against the economic costs of inadequate action; analysis shows 
that COVID-19 will cost the region between $37 and $79 billion in output losses in 2020 [5]. 
Waiting for assistance from donor countries is frowned upon by the Africa CDC [4] since aid 
was slow to arrive at the beginning of the pandemic. African countries can develop and 
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Community COVID-19 Screening Experiences 
In South Africa, approximately 28,000 Community Healthcare Workers (CHCWs) have been 
deployed. By the end of April 2020, over six million people were screened and 42,000 
referred for testing. Figure 1 shows COVID-19 screening activity by sub-district in Cape 
Town, the epicenter the pandemic in South Africa. A total of 16% of those screened were 
referred for testing at health facilities (range 4% - 48% by subdistrict). Table 1 describes the 
implementation challenges and possible solutions. 
 
While the Democratic Republic of the Congo (DRC) is confronting the COVID-19 crisis, its 
eastern northern province Kivu faces the last phase of its 10th Ebola virus disease (EBV) 
outbreak response in the last 40 years. The first confirmed COVID-19 case in DRC was 
reported on March 10th, 2020 in the capital city Kinshasa, and cases totaled 2,304 and 66 
deaths as of May 26th [4]. Figure 2 shows that as the proportion of imported cases 
decreases, there is steady increase of community transmission and confirmed positive 
contacts in Kinshasa, the epicenter of the epidemic in DRC. EBV infrastructure and human 
power experience in case finding are now being applied for the COVID-19 response. Also, 
the DRC government’s COVID-19 task response structure was incorporated into existing 
health structures tackling HIV, TB, malaria, and Non-Communicable Diseases (NCDs). ICAP 
at Columbia University’s Resilient and Responsive Health Systems (RRHS) project in DRC, 
supported by the U.S. Health Resources and Services Administration (HRSA), is 
implementing a multi-professional health team of nurses, midwives, doctors, pharmacists, 
medical students and CHCWs  in COVID-19 sensitization, screening and testing referral 
activities endorsed by the ministry of health, community, and faith leaders. 
 
The United Republic of Tanzania with 480 confirmed COVID-19 cases and 21 deaths as of 
May 26th, 2020 [1], introduced “Health Commandos,” CHCWs specific for the COVID-19 
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Trained and wearing special gear, they walked the streets educating the community on social 
distancing, hygiene measures, screening, and referrals for COVID-19 testing. In Rwanda, 
proactive screening, testing, isolation of confirmed first COVID-19 cases, and contact tracing 
led to travel bans and country lockdown, which helped flatten the curve and contain the 
epidemic with only 336 confirmed cases and no deaths as of May 26, 2020. Of note, 
screening is done mainly by doctors and other CHCWs. An innovative role for final-year 
medical students trained in sample collection, transportation, and analysis under the National 
Reference Laboratory allowed testing of 30,000 people as of April 30th, 2020: 243 were 
COVID-19 positive. Fortunately, most of the cases were young and asymptomatic, and 104 
recovered.  
 
In Mozambique, by end-May, there were more than 700,000 individuals screened, 15,090 
quarantined, and more than 8,796 individuals tested, from which 209 were positive for 
COVID-19. Unfortunately, displaced, and migrant populations (e.g., North and Central 
Mozambique) have not been reached for screening or implementation of mitigating measures 
due to political instability or terrorism. 
 
SARS-CoV-2 Testing: Logistics and Challenges 
Globally, the current gold standard test for SARS-CoV-2 infection is detection of viral RNA in 
a sample from the respiratory tract by RT-PCR [6-8]. Specialized laboratory facilities with 
skilled staff and expensive equipment to undertake these tests are scarce in most African 
countries. Centralized laboratories with testing facilities require samples to be transported, 
and thus turnaround times may be suboptimal, resulting in loss to follow-up.  Point-of-care 
(PoC) or near-patient solutions are preferable [9, 10]. The GeneXpert platform, already in 
place for TB testing across Africa, allows the use of SARS-CoV-2 cartridges, but drawbacks 
include cost and supply constraints. PoC viral antigen detection is not yet sufficiently 
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easier and safer than nasopharyngeal swabbing by healthcare staff. Serological testing for 
antiviral antibodies is now available [12] but only indicates recent or past infection and is 
unsuitable for diagnosing active COVID-19 cases. Importantly, seropositivity does not 
indicate immunity to SARS-CoV-2 [13]. However, antibody testing can allow reconstruction of 
transmission chains during outbreaks and community prevalence surveillance.  
 
Whilst the Africa CDC is facilitating regional collaborations and procurement and distribution 
of diagnostic tests across Africa, important operational and resource issues need to be 
addressed to avoid stockouts, supply-chain challenges, and competition among countries [4]. 
Incorporation of private and non-governmental sector laboratories in the rollout of testing and 
the use of existing available PoC diagnostic platforms for other diseases (e.g. TB, HIV) are 
promising strategies to improve availability and turnaround times and reduce reliance on 
central laboratories (Table 1). Ideally, diagnostic tests and reagents should be produced 
within Africa. Also, PoC COVID-19 testing at pharmacies may improve access to care and 
effective use of available healthcare workforce. 
 
Contact Tracing  
Case finding and contact tracing depend on substantial COVID-19 testing capability, sample 
throughput, and rapid turnaround times [14, 15]. In the Western Cape Province of South 
Africa, public and private laboratory results of confirmed COVID-19 cases are communicated 
electronically and assigned to provincially-based telephonic teams who then contact cases 
and their contacts.  Where this is not feasible, the persons concerned are relocated to 
designated isolation facilities. Cases and contacts are then monitored for 14 days. Workplace 
and airline contacts are also pursued. Legislation is available for mandatory isolation, should 
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In Rwanda, once a COVID-19 case is suspected, a sample is collected at a satellite site and 
sent to the National Reference Laboratory for testing, and the result is available within 10 
hours. If positive, the index case is isolated. Contact tracing entails the following steps: (1) 
case investigation procedure to identify all clinical symptoms; (2) memory history to recall all 
possible contacts during the window period, 2 to 14 days before the onset of the symptoms, 
who were within one meter of the index case; and (3) a roster of close contacts of the index 
case within the window period (for subsequent screening). As of April 30th, 2020, 3,657 
individuals linked to COVID-19 cases were traced by command posts across the country. 
 
In DRC and Tanzania, contact tracing is conducted by CHCWs using mobile phone calls and 
SMS and home visits if necessary. In selected provinces of DRC, a multi-professional health 
team described earlier is being implemented for contact tracing by RRHS project. In 
Mozambique, contact tracing is done by the staff of the National Institute of Health, medical 
residents, and students from the Master Program on Field Epidemiology and Laboratory 
Training Program (FELTP) supported by CDC [16]. These cadres are trained and skilled in 
applying a screening epidemiological case identification tool and on procedures for contact 
tracing and surveillance of quarantined individuals and home-isolated COVID-19 cases. This 
strategy has proven effective thus far because of the limited number of cases and contacts to 
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Conclusions and Way Forward  
Resource-constrained African governments face difficult choices regarding surveillance and 
easing of lockdown.  Control of the COVID-19 pandemic will be possible only with efficient 
community screening, testing, and contact tracing and behavioral change interventions, 
which require adequate resources and a well-supported, community-based team of trained, 
protected personnel. Every part of this public health chain needs to be strengthened. With an 
already understaffed health force, Africa cannot afford the 10% infection rate of healthcare 
workers seen in selected European countries. This crisis presents a unique opportunity to 
align COVID-19 services with those in already place for HIV, TB, Malaria, and NCDs through 
mobilization of Africa's inter-professional healthcare workforce to contain the pandemic. By 
addressing the challenges, the detrimental effect of the COVID-19 pandemic on African 
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Figure 1. COVID-19 Community Screening by sub-district in Cape Town, South Africa, April 4th to 
May 22nd, 2020, Cape Town, South Africa 
 



















 Table 1.  Challenges and possible Solutions for Scaling-Up COVID-19 Community-Based 
Screening, Testing and Contact Tracing Experiences from Select African Countries    
 
 
 Target Country 
by Burden 
Early and late Challenges Priority Solutions 
1 South Africa  Fake news adding to 
anxiety, rejection, and non-
cooperation 
 Staff anxiety about the risk 
of SARS-CoV2 infection 
 Rejection and racism 
experienced by some 
CHCWs due to clashing 
cultures, language barriers 
 Stigmatization of the 
workers by the 
communities based on their 
wearing of PPE 
 Some communities’ 
outright rejection of 
screening 
 Long turn-around time of 
PCR results 
 Small spaces within the 
houses visited, 
overcrowding in some 
houses 
 Elderly and disabled cannot 
reach screening/testing 
sites 
 Hard to reach populations: 
homeless, sex workers, 
children, essential workers, 
prisoners 
 Instability of mobile device 
apps for collecting 
household data 
 Difficulty in obtaining GPS 
data of home visits 
 Parallel data collection 
system requirements for 
the Department of Health 
and external funders 
 Ongoing communication to 
communities, in local languages using 
multiple platforms and players to 
immediately address inaccuracies 
circulating on social media by 
        using authoritative voices- daily myth 
busters 
 Active and regular use of symptom 
self-screening tools by staff & 
communities 
 Active daily monitoring of symptoms 
with feedback from management 
 Temperature monitoring of staff and 
people screened makes for greater 
reassurance 
 Ease access to testing for staff by 
having testing centers at workplaces 
 PoC COVID-19 testing at pharmacies 
 Support staff during their quarantine 
while waiting for results- especially 
with management of their 
households/families/children 
 Improve the turnaround time for staff 
SARS-CoV2 PCR testing outcomes 
 Referral service whereby communities 
and their household members can 
access telephonic assistance and 
counselling and face-to-face emotional 
support, if required 
2 Democratic 
Republic of the 
Congo 
 
 Some community members 
do not believe that disease 
exists 
 Poverty levels limit respect 
for the application of barrier 
measures 
 Screening is centralized at 
the national level, which 
causes a delay in delivery 
of results to provinces 
 Contact tracing is done 
only by a small team in 
provinces due to shortage 
 
 Scale-up community COVID-19 
sensitisation and barrier measures in 
public places 
 Leverage infrastructure, human 
resources, & training platform of Ebola 
Viral Disease for COVID-19 
 Decentralization of screening and PCR 
testing using PoC machines in 
provinces 
 Increase contributions of government 
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of PPEs 
 Shortage of GeneXpert 
machines 
 Shortage of 
reagents/cartridges with 
increased demand for 
suspected COVID-19 
cases 
3 Tanzania  Shortage of PPE 
 Laboratory testing 
insufficiencies 
 Shortage of adequately 
trained CHCWs 
 Build local capacity to produce PPE 
 Refurbish the National reference 
laboratory 
 Scale-up trained multi-professional 
CHCWs for COVID-19 screening. 
Testing and contact tracing 
4 Rwanda  Limited laboratory capacity 
to run 1500 or more tests 
per day 
 Long turnaround time of 
PCR results, especially for 
people quarantined in 
peripheral sites  
 Difficult to track movement 
of truck drivers using 
modern devices and GPS 
 Pooled testing approach for COVID-19 
mass testing 
 Test GeneXpert platform for COVID19 
for phases 2-3 of lockdown 
 Establishment of COVID-19 testing 
capacity using existing platforms at 
decentralized level 
 Use of tracking devices embedded with 
GPS for trucks drivers 
5 Mozambique  Limited financial resources 
to purchase diagnostic kits 
and other related supplies 
 Limited laboratory 
infrastructure to process 
samples 
 Limited number of 
laboratory technicians to 
process samples  
 Scarcity PPE for health 
workforce within National 
Health Service 
 Fear and anxiety among 
health workforce for the risk 
of SARS-CoV2 infection 
 Myths and misconceptions 
about cause of COVID-19 
 Poverty and lack of formal 
employment, which makes 
it difficult to keep affected 
people in confinement 
 Hard to reach populations: 
people living in areas of 
armed conflicts  
 Fund mobilization trough external 
Government entities, academia 
philanthropic institutions, and civilian 
community 
 Optimize and share existing 
GeneXpert platform for TB testing and 
other PCR equipment from other 
research laboratories 
 Refresh and train existing laboratory 
technicians working in molecular 
diagnosis throughout the country  
 Providing PPEs and refreshment 
trainings on biosafety measures and 
ensuring social support in case health 
workforce get infected 
 Strong advocacy and use of all mean 
of communication to increase 
awareness of disease within the 
population 
 Distribution by the Government and 
partners of basic food baskets and 
other necessities  
 Strengthening of Epidemiological 
Surveillance, identification of cases 
and contact tracing, and monitoring of 
individuals in quarantine and isolation 
 Strengthening of hospitalization 
conditions for covid-19 patients with 
moderate to severe diseases and 
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RT-PCR: Reverse Transcriptase Polymerase Chain Reaction; CHCWs: Community Healthcare Workers; 
COVID-19: Coronavirus Diseases 2019; SARS-coV2: Severe Acute Respiratory Syndrome Coronavirus 
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